Find a Clinical Trial
Is a clinical trial right for you? Search our database to find studies for which you may be eligible.
Smoking Cessation and Brain Activation: How practice changes the brain
Study Type: Prevention
Phase: N/A
NCTID: NCT03080844
Principal Investigator:
Laura Martin
Testing for Atypia in Random Periareolar Fine Needle Aspiration RPFNA Cytology after 12 Months Metformin 1, 1-Dimethylbiguanide Hydrochloride Chemoprevention versus Placebo Control in Premenopausal Women
A Multicenter Study of 5-Aminolevulinic Acid 5-ALA to Enhance Visualization of Malignant Tumor in Patients with Newly Diagnosed or Recurrent Malignant Gliomas: A Safety, Histopathology, and Correlative Biomarker Study
A Randomized, Multicenter, Phase III Trial of Tacrolimus/Methotrexate versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation
Omega 3 Fatty Acids in Colorectal Cancer CRC Prevention in Patients with Lynch Syndrome COLYNE
Study Type: Prevention
Phase: Feasibility/Pilot
NCTID: NCT03831698
Principal Investigator:
Anwaar Saeed
Pharmacologic Reversal of Ventricular Remodeling in Childhood Cancer Survivors at Risk for Heart Failure PREVENT-HF: A Phase 2b Randomized Placebo-Controlled Carvedilol Trial
Study Type: Prevention
Phase: II
NCTID: NCT02717507
Principal Investigator:
Keith August
A Phase 3, Randomized, Adaptive Study Comparing the Efficacy and Safety of Defibrotide vs Best Supportive Care in the Prevention of Hepatic Veno-Occlusive Disease in Adult and Pediatric Patients Undergoing Hematopoietic Stem Cell Transplant
Study Type: Prevention
Phase: III
NCTID: NCT02851407
Principal Investigator:
Rakesh Goyal
Effectiveness of the SpaceOAR Vue System in Subjects with Prostate Cancer being Treated with Stereotactic Body Radiotherapy SABRE
Study Type: Prevention
Phase: N/A
NCTID: NCT04905069
Principal Investigator:
Ronald Chen
Changing the Default for Tobacco Treatment
Study Type: Prevention
Phase: IV
NCTID: NCT02721082
Principal Investigator:
Kimber Richter